DUPILUMAB Pharmacologic Class Indexing
- Class set ID
- dfeb1e65-4bfa-40b8-9b7b-be18d54c2993
- Version
- 2
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use DUPIXENT safely and effectively. See full prescribing information for DUPIXENT. DUPIXENT ® (dupilumab) injection, for subcutaneous use Initial U.S. Approval: 2017 | Sanofi-Aventis U.S. LLC | Regeneron Pharmaceuticals, Inc. | Sanofi Winthrop Industrie | Sanofi-Aventis Deutschland GmbH | Genzyme Ireland Limited | Regeneron Ireland Designated Activity Company | 20260422 | 56 |